Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Forest Laboratories

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Forest Laboratories 2013 CNS and cardiovascular sales performance.

Forest Laboratories

Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel He has held numerous leadership roles including president and CEO of Aptalis Pharma prior to its acquisition by Forest Laboratories.

PharmaLex appoints Zabin Younes as associate director

PharmaLex appoints Zabin Younes as associate director In addition she also has over ten years of management experience and has set up and managed research teams, GMP testing laboratories and led MHRA/FDA corporate audits.

Nova appoints Richard Limb as head of quality assurance

Nova appoints Richard Limb as head of quality assurance He joins the privately-owned company from Pfizer. Leicester, UK-based Nova Laboratories has appointed Richard Limb as its new head of quality assurance in a role that will see him

Roche and the Pipeline Laboratory

Roche and the Pipeline Laboratory. ... Roche and the Pipeline Laboratory - by Virgo Health for Roche UK.

In Their Shoes

Roche and the Pipeline Laboratory. ... Roche and the Pipeline Laboratory - by Virgo Health for Roche UK.

[ Previous 5 results ] 14 15 16 17 18 19 20 21 22 23 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics